References
1. Blackman AC, Staggers KA, Kronisch L, et al. Quality of life improves
significantly after real-world oral immunotherapy for children with
peanut allergy. Ann Allergy Asthma Immunol. 2020;125(2):196-201 e1.
2. Gradman J, Halken S. Preventive Effect of Allergen Immunotherapy on
Asthma and New Sensitizations. J Allergy Clin Immunol Pract. 2021.
3. Shamji MH, Layhadi JA, Sharif H, et al. Immunological Responses and
Biomarkers for Allergen-Specific Immunotherapy Against Inhaled
Allergens. J Allergy Clin Immunol Pract. 2021.
4. Pfaar O, Agache I, Bonini M, et al. COVID-19 pandemic and allergen
immunotherapy - an EAACI survey. Allergy. 2021.
5. Klimek L, Pfaar O, Worm M, et al. Allergen immunotherapy in the
current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI
and GPA: Position paper of the German ARIA Group(A) in cooperation with
the Austrian ARIA Group(B), the Swiss ARIA Group(C), German Society for
Applied Allergology (AEDA)(D), German Society for Allergology and
Clinical Immunology (DGAKI)(E), Society for Pediatric Allergology
(GPA)(F) in cooperation with AG Clinical Immunology, Allergology and
Environmental Medicine of the DGHNO-KHC(G) and the European Academy of
Allergy and Clinical Immunology (EAACI)(H). Allergol Select.
2020;4:44-52.
6. Hettinga J, Carlisle R. Vaccination into the Dermal Compartment:
Techniques, Challenges, and Prospects. Vaccines (Basel). 2020;8(3).
7. Bird JA, Sanchez-Borges M, Ansotegui IJ, et al. Skin as an immune
organ and clinical applications of skin-based immunotherapy. World
Allergy Organ J. 2018;11(1):38.
8. Wang J, Sampson HA. Safety and efficacy of epicutaneous immuntherapy
for food allergy. Pediatr Allergy Immunol. 2018;29.
9. Scurlock AM, Burks AW, Sicherer SH, et al. Epicutaneous immunotherapy
for treatment of peanut allergy: Follow-up from the Consortium for Food
Allergy Research. J Allergy Clin Immunol. 2021;147(3):992-1003 e5.
10. Xiong L, Lin J, Luo Y, et al. The Efficacy and Safety of
Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review
and Meta-Analysis. Int Arch Allergy Immunol. 2020;181(3):170-182.
11. Chuang YY, Lin CS, Wang CH, et al. Distribution and seasonal
occurrence of Forcipomyia taiwana (Diptera: Ceratopogonidae) in the
Nantou area in Taiwan. J Med Entomol. 2000;37(2):205-209.
12. Chen YH, Lee MF, Lan JL, et al. Hypersensitivity to Forcipomyia
taiwana (biting midge): clinical analysis and identification of major
For t 1, For t 2 and For t 3 allergens. Allergy. 2005;60(12):1518-1523.
13. Chan KL, Saunders LG. Forcipomyia (Dacnoforcipomyia) Anabenae, a New
Blood-Sucking Midge from Singapore, Described in All Stages (Diptera,
Ceratopogonidae). Can J Zool. 1965;43:527-540.
14. Szadziewski R. [Forcipomyia (Lasiohelea) sibirica (Diptera,
Ceratopogonidae) in Poland]. Wiad Parazytol. 1991;37(1):57-60.
15. Urbanek A, Richert M, Gilka W, et al. Morphology and histology of
secretory setae in terrestrial larvae of biting midges of the genus
Forcipomyia (Diptera: Ceratopogonidae). Arthropod Struct Dev.
2011;40(6):485-494.
16. Marino PI, Spinelli GR. Biting midges of the Forcipomyia
(Forcipomyia) argenteola group in southern South America, with
description of a new species and a key to the neotropical species
(Diptera: Ceratopogonidae). Rev Biol Trop. 2008;56(2):789-794.
17. Huerta H, Spinelli GR. A distinctive new species of biting midge in
the subgenus Euprojoannisia Brethes from Mexico with new records
of Neotropical species of Forcipomyia Meigen (Diptera:
Ceratopogonidae). Zootaxa. 2017;4329(2):189-195.
18. Chen YH, Hwang GY, Chen PC, et al. Molecular cloning and immunologic
characterization of for t 2: a major allergen from the biting midgeForcipomyia taiwana . Allergy. 2011;66(5):703-705.
19. Chen YH, Lee MF, Tsai JJ, et al. Specific IgE and IgG responses and
cytokine profile in subjects with allergic reactions to biting midgeForcipomyia taiwana . Int Arch Allergy Immunol. 2009;150(1):66-74.
20. Lee MF, Song PP, Lin TM, et al. For t 2 DNA vaccine preventsForcipomyia taiwana (biting midge) allergy in a mouse model.
Allergy. 2016;71(4):522-531.
21. Lee MF, Chen YH, Song PP, et al. Therapeutic DNA vaccine attenuates
itching and allergic inflammation in mice with established biting midge
allergy. PLoS One. 2020;15(4):e0232042.
22. Lee MF, Yang KJ, Wang NM, et al. The development of a murine model
for Forcipomyia taiwana (biting midge) allergy. PLoS One.
2014;9(3):e91871.
23. Trommer H, Neubert RH. Overcoming the stratum corneum: the
modulation of skin penetration. A review. Skin Pharmacol Physiol.
2006;19(2):106-121.
24. Wang Y, Kong Y, Wu MX. Innovative Systems to Deliver Allergen Powder
for Epicutaneous Immunotherapy. Front Immunol. 2021;12:647954.
25. Balmert SC, Carey CD, Falo GD, et al. Dissolving undercut
microneedle arrays for multicomponent cutaneous vaccination. J Control
Release. 2020;317:336-346.
26. Erdos G, Balmert SC, Carey CD, et al. Improved Cutaneous Genetic
Immunization by Microneedle Array Delivery of an Adjuvanted Adenovirus
Vaccine. J Invest Dermatol. 2020;140(12):2528-31 e2.
27. Lademann J, Richter H, Schanzer S, et al. Follicular penetration of
nanocarriers is an important penetration pathway for topically applied
drugs. Hautarzt. 2019;70(3):185-192.
28. Ozturk AB, Baccioglu A, Soyer O, Civelek E, Sekerel BE, Bavbek S.
Change in Allergy Practice during the COVID-19 Pandemic. Int Arch
Allergy Immunol. 2021;182(1):49-52.